Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis

C. Pickard, C. Mann, P. Sinnott, M. Boggild, C. Hawkins, R. C. Strange, I. V. Hutchinson, W. E R Ollier, R. P. Donn

    Research output: Contribution to journalArticlepeer-review


    Interleukin-10 (IL10) is an anti-inflammatory cytokine which may modulate disease expression in multiple sclerosis (MS). Three dimorphic polymorphisms within the IL10 promoter region at positions -1082, -819 and -519 have previously been identified. The -1082*A allele has been associated with low and the -1082*G allele with high in vitro IL10 production. We have genotyped 185 Caucasian MS patients and 211 ethnically matched controls for each of these three dimorphisms. MS patients were stratified for severity of disease outcome. No associations were found for any IL10 promoter polymorphisms when the MS cases were compared with controls or with disease outcome with regards to disability. IL10 polymorphism does not appear to be associated with MS or to influence disease progression. Copyright (C) 1999 Elsevier Science B.V.
    Original languageEnglish
    Pages (from-to)207-210
    Number of pages3
    JournalJournal of neuroimmunology
    Issue number2
    Publication statusPublished - 15 Nov 1999


    • Disease severity
    • Interleukin-10
    • Multiple sclerosis


    Dive into the research topics of 'Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis'. Together they form a unique fingerprint.

    Cite this